CureVac plans global late-stage Covid-19 vaccine trial in fourth quarter
CureVac plans global late-stage Covid-19 vaccine trial in fourth quarter CureVac has dosed the first patient with its experimental Covid-19 vaccine in the trial taking place in Peru and Panama and expects data on older adults in the fourth quarter. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment